AlzChem Group AG
General ticker "ALZCF" information:
- Sector: Materials
- Industry: Chemicals - Specialty
- Capitalization: $1.7B (TTM average)
AlzChem Group AG follows the US Stock Market performance with the rate: 40.9%.
Estimated limits based on current volatility of 3.6%: low 179.71$, high 193.06$
Factors to consider:
- Company pays dividends (annually): last record date 2026-05-07, amount 2.47$ (Y1.38%)
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [108.53$, 180.25$]
- 2026-12-31 to 2027-12-31 estimated range: [94.87$, 161.59$]
Financial Metrics affecting the ALZCF estimates:
- Negative: with PPE of 23.0 at the end of fiscal year the price was high
- Positive: 7.78 < Operating profit margin, % of 14.73
- Positive: 6.73 < Operating cash flow per share per price, % of 9.55
- Negative: Investing cash flow per share per price, % of -6.75 <= -4.44
- Positive: 19.10 < Shareholder equity ratio, % of 41.49 <= 42.34
- Positive: Return on assets ratio (scaled to [-100,100]) of 9.34 > 6.08
- Positive: 0 < Industry operating cash flow per share per price (median), % of 5.24
- Negative: 0 < Industry inventory ratio change (median), % of 0.12
- Positive: Interest expense per share per price, % of 0.12 <= 0.75
Short-term ALZCF quotes
Long-term ALZCF plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | €540.65MM | €554.23MM | €561.90MM |
| Operating Expenses | €397.35MM | €476.11MM | €479.15MM |
| Operating Income | €143.30MM | €78.13MM | €82.76MM |
| Non-Operating Income | €-95.11MM | €-2.78MM | €5.15MM |
| Interest Expense | €7.66MM | €5.83MM | €1.73MM |
| R&D Expense | €11.41MM | €10.83MM | €10.70MM |
| Income(Loss) | €48.19MM | €75.34MM | €87.91MM |
| Taxes | €13.40MM | €21.10MM | €24.30MM |
| Net Income(Loss)* | €34.62MM | €54.08MM | €63.44MM |
| Stockholders Equity | €161.62MM | €205.54MM | €256.20MM |
| Assets | €424.68MM | €483.83MM | €617.45MM |
| Operating Cash Flow | €72.67MM | €105.15MM | €136.96MM |
| Capital expenditure | €20.56MM | €43.10MM | €97.75MM |
| Investing Cash Flow | €-20.55MM | €-30.99MM | €-96.87MM |
| Financing Cash Flow | €-49.17MM | €-24.66MM | €-29.35MM |
| Earnings Per Share** | €3.40 | €5.31 | €6.28 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.